Pediatric primary cardiac tumors: diagnosis and treatment

Avihu Z Gazit1, Sanjiv K Gandhi

  • 1Department of Pediatrics, Washington University in Saint Louis, One Children's Place, NWT Box 8116, St. Louis, MO 63110, USA. gazit_a@kids.wustl.edu

Insights

Pediatric primary cardiac tumors like rhabdomyomas and fibromas are rare, with distinct fetal and neonatal presentations. Early diagnosis and specialized care at tertiary centers are crucial for optimal outcomes.

Area of Science:

  • Pediatric Cardiology
  • Fetal and Neonatal Medicine
  • Pediatric Oncology

Background:

  • Primary cardiac tumors are uncommon in children.
  • Clinical manifestations vary significantly across pediatric age groups, from fetus to young adult.
  • This review focuses on specific tumors: rhabdomyomas, fibromas, myxomas, and pericardial teratomas in fetuses and neonates.

Purpose of the Study:

  • To outline the diagnostic approaches for fetal and neonatal primary cardiac tumors.
  • To describe the management strategies for these rare pediatric conditions.
  • To emphasize the importance of specialized care in tertiary centers.

Main Methods:

  • Review of diagnostic methods including echocardiography for fetal diagnosis.
  • Discussion of clinical presentations prompting neonatal diagnosis (murmur, dysrhythmia, obstruction).
  • Outline of emergent interventions and surgical considerations.

Main Results:

  • Fetal diagnosis is possible for rhabdomyomas, fibromas, and pericardial teratomas, often linked to specific fetal conditions.
  • Neonatal diagnosis may be triggered by symptoms of cardiac compromise or obstruction.
  • Prenatal diagnosis of significant masses requires immediate neonatal intensive care and potential interventions like prostaglandin E(1) or balloon atrial septostomy.

Conclusions:

  • Referral to a tertiary center is essential for comprehensive evaluation and management of fetal and neonatal cardiac tumors.
  • Prompt multidisciplinary intervention, including advanced life support and potential surgery, is critical for neonates with hemodynamically significant tumors.
  • Early diagnosis and management significantly impact the prognosis for pediatric patients with primary cardiac tumors.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...